MedPacto, Inc., a genome-based drug discovery and clinical-stage biotechnology company, announced on Feb. 11 that it has partnered with HITS, an artificial intelligence (AI) drug discovery company, to co-develop new drugs.Under the terms of the agreement, the two companies will practice drug develop
Korea's nuclear phase-out policy is called into question as the European Commission has finally classified nuclear power generation as part of a green economy. The commission mapped out on Feb. 2 (local time) a plan to include investment in nuclear power and natural gas power generation in its g
The author is a fixed income strategist of Shinhan Investment Corp. He can be reached at jk.ahn@shinhan.com. -- Ed. Base rate to remain unchanged in February but upward pressure on KTB yields to continue ahead of presidential election in MarchThe government will likely need more supplementary budget
LG Energy Solution announced on Jan. 25 (U.S. local time) that Ultium Cells, a joint venture company with GM, will build its third electric vehicle battery plant in Lansing, Michigan of the United States by investing US$2.6 billion. Ground will be broken for the new plant in 2022 for completion in t
Northvolt has signed or is considering signing deals with Korean companies with regard to supply of the four major battery materials -- anode materials, cathode materials, separators and electrolyte.Northvolt is a company set up in 2016. It receives strong support from the European Union (EU), which
Medpacto, a new drug developer that recently stirred up controversy due to two patient deaths during a clinical trial and the rejection of a change in the clinical trial plan, announced on Jan. 14 that its CEO Kim Sung-jin bought 24,780 treasury shares.According to the disclosure, the price per shar
The author is an analyst of NH Investment & Securities. He can be reached at minjae.lee@nhqv.com. -- Ed. KEPCO is forecast to log a 1H22 operating loss of W9.0tn. On a consolidated basis, debt-to-equity ratio will likely climb to 250% by end-2022. In our view, the firm looks to be at bottom in terms
LG Chem announced on Jan. 19 that it has received approval from the US FDA for clinical phase 1 studies (investigational new drug; IND) for ‘LC542019,’ which is a new drug candidate material for treating type 2 diabetes that can improve insulin resistance.With the approval, LG Chem has now procured
The authors are analysts of Shinhan Investment Corp. They can be reached at kimaram@shinhan.com & mj1224@shinhan.com, respectively. -- Ed. Leading the market for job matching platformsWanted Lab started off in 2015 as a human resources (HR) solution provider and currently operates the job matching p
Korea’s biotech venture ABL Bio has licensed out its new drug candidate to Sanofi, the world’s sixth-largest pharmaceutical company in France, in a deal worth up to 1.27 trillion won.“We have signed a technology transfer contract with Sanofi for Parkinson’s disease treatment ABL301,” ABL Bio said in
The author is a fixed income strategist of Shinhan Investment Corp. He can be reached at jk.ahn@shinhan.com. -- Ed. US December jobs report justifies monetary tighteningThe 3Y and 10Y KTB yields have gone up 23bp and 20bp, respectively, since the start of the year. The domestic bond market has been
The author is an analyst of NH Investment & Securities. He can be reached at minjae.lee@nhqv.com. -- Ed. With the acquisition by Jungheung Construction now finalized, Daewoo E&C no longer enjoys a previously granted valuation premium. Since the takeover decision was made, Daewoo E&C’s share price ha
The author is an analyst of NH Investment & Securities. He can be reached at minjae.lee@nhqv.com. -- Ed. In 2021, Hyundai E&C secured W5.5tn worth of urban renewal projects, including remodeling projects. The firm’s solid track record buildup in the power market should make it an attractive mid/long
Samsung Electronics is expected to announce large-scale merger and acquisition (M&A) deals soon. German chipmaker Infineon Technologies and Dutch semiconductor company NXP Semiconductor have emerged as Samsung's M&A targets as it aims to foster its non-memory business.“I think we will be able to
Shares of Shinsegae fell more than 6% on Jan. 10. The plunge is attributed to a contraction in investor sentiment caused by Shinsegae Group vice chairman Chung Yong-jin's controversial Instagram posts.Shinsegae's stock price closed at 233,000 won, down 17,000 won or 6.8% from the previous tr
Samsung Electronics’ quantum dot (QD)-organic light emitting diode (OLED) TV has nabbed the Best of Innovation award at CES 2022, which kicks off in Las Vegas of the United States on Jan. 5 (local time). Samsung Electronics has decided not to display the product at this year's CES, but industry
CJ CheilJedang launched CJ Bioscience, a subsidiary specializing in pharmaceuticals and healthcare, on Jan. 5. The new company is a combination of CJ CheilJedang's red bio unit and Chunlab, a microbiome company acquired by CJ CheilJedang in October 2021.At the launching ceremony, CJ Bioscience p
Hanmi Pharmaceutical has exported a new drug candidate, which it licensed from a U.S. company six years ago, to a Chinese corporation.This is the first time that Hanmi Pharmaceutical has exported a new drug technology acquired from outside.Hanmi Pharmaceutical announced on Jan. 3 that it signed a co
POSCO International, the trading arm of POSCO Group, is pushing to establish a motor core plant in Eastern Europe. Motor cores are a key component of electric vehicles that generates electricity.POSCO International and POSCO SPS, a 100 percent subsidiary of the trading company that produces motor co
EOFlow Co., a Korean pharmaceutical company specializing in wearable drug delivery solutions, announced on Dec. 28 that its wholly owned U.S. subsidiary, EOFlow Inc. has signed an agreement to establish a joint venture in the U.S. with the U.K. biotech firm Zihipp Limited, a spin-off from Imperial C